Cornetto (frozen dessert)
Cornetto is a branded frozen dessert cone, which is manufactured by Unilever under its Heartbrand product line, available in various flavors. The Cornetto is made up of a crispy baked wafer, coated inside from top to bottom with a chocolate layer, filled with flavored ice cream, and topped with a chocolate disk sprinkled with nuts, depending on the variant. It was first produced in 1959 in Italy by Spica, a company that Unilever acquired in the 1970s, and has since become a popular ice cream product sold in many countries around the world.
History
The Cornetto was originally developed by Spica, an Italian ice-cream manufacturer, as a solution to enjoy ice cream cleanly without the mess of the melting cream. The idea was to create a cone with a solid chocolate layer inside that would prevent the ice cream from leaking out as it melts. This innovation proved to be a success, leading to the acquisition of Spica by Unilever in the 1970s, which helped to globalize the brand.
Varieties
Over the years, the Cornetto has been made available in a wide range of flavors to cater to diverse tastes and preferences. Some of the popular flavors include:
- Vanilla
- Chocolate
- Strawberry
- Mint Chocolate
- Tiramisu
Each variety is designed to offer a unique taste experience, combining the textures of the crispy wafer, the creamy ice cream, and the rich toppings.
Marketing
Unilever has employed various marketing strategies to promote the Cornetto brand globally. This includes catchy advertising campaigns, partnerships, and the use of social media to engage with a younger audience. The slogan "Enjoy the Ride, Love the Ending" is one of the memorable marketing messages that have been used to encapsulate the experience of enjoying a Cornetto.
Cultural Impact
The Cornetto has not only become a popular frozen dessert but has also made its mark in popular culture. It has been featured in films, music videos, and has inspired the name of the "Cornetto Trilogy," a series of films directed by Edgar Wright.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
